最高静脉血栓栓塞风险患者与较低风险患者相比的静脉血栓栓塞及不良结局
该单中心回顾性队列研究纳入2013至2018年24303例>20周分娩,比较高危(395例,1.7%,接受门诊肝素类预防或治疗)与低危(23905例,98.3%,无门诊抗凝)患者的结局。高危患者血栓栓塞风险为低危的11倍(校正OR 11.1 [4.7-26.2]),伤口/会阴血肿风险亦升高(校正OR 4.8 [2.7-8.4])。
要点
- 高危患者血栓栓塞风险为低危的11倍(校正OR 11.1 [4.7-26.2])。
- 高危患者伤口/会阴血肿风险为低危的4.8倍(校正OR 4.8 [2.7-8.4])。
- 高危患者总体伤口并发症、输血、ICU入住、孕产妇死亡及住院时间均更多。
核心结论
- 最高产科血栓栓塞风险患者的血栓栓塞风险为低危患者的11倍,产后伤口及出血并发症风险约升高5倍(校正OR 4.8 [2.7-8.4])。
- 这一更有利的风险或获益特征支持当前对高危患者的抗凝推荐。
研究设计与样本
- 单中心回顾性队列研究,纳入2013至2018年所有>20周分娩,共24303例。
- 高危组395例(1.7%)接受门诊肝素类预防或治疗,低危组23905例(98.3%)无门诊抗凝。
- 主要结局为产后新诊断血栓栓塞,次要结局为伤口/会阴血肿,以低危组为参照计算校正OR及95%CI。
主要发现
- 低危患者中8.6%按照本院基于风险的住院血栓栓塞预防方案接受了抗凝预防。
- 高危患者更可能年龄较大、BMI更高、分娩孕周更早,并合并内科疾病及妊娠并发症如子痫前期。
- 尽管接受门诊产前抗凝,高危患者血栓栓塞风险仍为低危的11倍(校正OR 11.1 [4.7-26.2])。
- 高危患者伤口/会阴血肿显著更多(校正OR 4.8 [2.7-8.4]),总体伤口并发症亦更多(校正OR 3.0 [2.0-4.4])。
- 高危患者输血、ICU入住、孕产妇死亡及孕产妇住院时间延长均更多。
临床怎么用
- 原文结论认为这一更有利的风险或获益特征支持当前对高危患者的抗凝推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A risk-based institutional protocol for inpatient heparin-based venous thromboembolism prophylaxis in a general obstetrical population previously demonstrated a greater than 2-fold increase in wound hematomas with no change in the frequency of thromboembolism. OBJECTIVE: We sought to compare the rates of thromboembolism and bleeding outcomes in patients at the highest risk for thromboembolism (eg, those with a history of thromboembolism or thrombophilia who require anticoagulation prophylaxis or therapy throughout pregnancy) than low-risk patients. STUDY DESIGN: We performed a retrospective cohort study of all deliveries >20 weeks at a single center from 2013-2018. Patients were categorized as high-risk (received outpatient heparin-based prophylaxis or treatment) or low-risk (no outpatient anticoagulation). The primary outcome was newly diagnosed postpartum thromboembolism; the main secondary outcome was wound/perineal hematoma. The outcomes were compared between the high- and low-risk cohorts. Adjusted odds ratios (with 95% confidence intervals) were calculated with the low-risk group as reference. RESULTS: Of 24,303 total deliveries, 395 (1.7%) were high-risk and 23,905 (98.3%) were low-risk. Among the low-risk patients, 8.6% received anticoagulation prophylaxis in accordance with our risk-based inpatient thromboembolism prophylaxis protocol. High-risk patients were more likely to be older and have a higher body mass index, earlier delivery gestational age, medical comorbidities, and pregnancy complications, eg, preeclampsia. Despite outpatient antepartum anticoagulation, high-risk patients had an 11-fold increased risk of thromboembolism (adjusted odds ratio, 11.1 [4.7-26.2]) than low-risk patients. High-risk patients also had significantly more wound/perineal hematomas (adjusted odds ratio, 4.8 [2.7-8.4]), overall wound complications (adjusted odds ratio, 3.0 [2.0-4.4]), blood transfusions, intensive care unit admissions, maternal deaths, and longer maternal lengths of stay. CONCLUSION: Patients at the highest risk of obstetrical thromboembolism had an 11-fold increased risk of thromboembolism with a more moderate increase (∼5-fold) in postpartum wound and bleeding complications than low-risk patients. This more favorable risk or benefit profile supports current anticoagulation recommendations in high-risk patients.
引用
- Page MR, Cozzi GD, Blanchard CT, et al. Venous thromboembolism and adverse outcomes in highest thromboembolism risk patients compared with those at lower risk. Am J Obstet Gynecol MFM. 2022. PMID: 35977704. doi:10.1016/j.ajogmf.2022.100720
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。